Julie Segal Novartis CEO Joseph Jimenez Pushes Drug Discovery When Joseph Jiminez took over as Novartis CEO he invested heavily in R&D and expanded into emerging markets. He speaks to Institutional Investor Senior Writer Julie Segal. Julie Segal February 15, 2012